Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Cholangiocarcinoma and Gallbladder Cancer Studies

TopicLeading institutions, researchers & key papers

This cluster of papers focuses on the diagnosis, management, epidemiology, and therapeutic strategies for cholangiocarcinoma, including intrahepatic and hilar cholangiocarcinoma. It covers topics such as surgical management, molecular pathology, and prognostic factors. The papers also discuss the increasing incidence and mortality of biliary tract cancers, as well as emerging targeted therapies.

530
Works

How has Cholangiocarcinoma and Gallbladder Cancer Studies's publication output changed over time?

ScholarIQpublication output · 2006–2023

Output grew0% over the shown period — from 1 works in 2006 to 1 in 2023.

1
1
1
3
1
1
2
2
1
1
2006200720112014201620172020202120222023

What are the most-cited papers on Cholangiocarcinoma and Gallbladder Cancer Studies?

ScholarIQmost cited works
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass, Vésteinn Thórsson, Ilya Shmulevich, Sheila M. Reynolds, Michael Miller, Brady Bernard, Vésteinn Thórsson, Lisa Iype, Roger Kramer, Richard Kreisberg, Hector Rovira, Natalie Tasman, Toshinori Hinoue, P O Laird, Hui Shen, Daniel J. Weisenberger, Moiz Bootwalla, Phillip H. Lai, Timothy J. Triche, David Van Den Berg, Christina Curtis, Nikolaus Schultz, Nils Weinhold, r B. Arman Askoy, Giovanni Ciriello, Gideon Dresdner, Jianjiong Gao, Benjamin Gross, Anders Jacobsen, William Lee, Ricardo Ramírez, Chris Sander, Yasin Şenbabaoğlu, Rileen Sinha, S. Onur Sumer, Yichao Sun, Ronglai Shen, David P. Kelsen, Yelena Y. Janjigian, Reanne Bowlby, Andy Chu, Katayoon Kasaian, Andrew J. Mungall, A. Gordon Robertson, Payal Sipahimalani, Adrian Ally, Miruna Balasundaram, İnanç Birol, Denise Brooks, Yaron S.N. Butterfield, Rebecca Carlsen, Justin Chu, Eric Chuah, Hye-Jung E. Chun, Amanda Clarke, Noreen Dhalla, Ranabir Guin, Robert A. Holt, Steven J.M. Jones, Darlene Lee, Haiyan A. Li, Emilia L. Lim, Yussanne Ma, Marco A. Marra, Michael Mayo, Richard A. Moore, Karen Mungall, Ka Ming Nip, Jacqueline E. Schein, Angela Tam, Nina Thiessen, Andrew Cherniack, Gad Getz, Yingchun Liu, Michael S. Noble, Chandra Pedamallu, Carrie Sougnez, Amaro Taylor‐Weiner, Michael S. Lawrence, Kristian Cibulskis, Lee Lichtenstein, Sheila Fisher, Stacey Gabriel, Eric S. Lander, Rameen Beroukhim, Scott L. Carter, Andrew D. Cherniack, Juok Cho, Daniel DiCara, Scott Frazer, Nils Gehlenborg, David I. Heiman, Joonil Jung, Jaegil Kim, Pei Lin, Matthew Meyerson, Akinyemi I. Ojesina, Chandra Sekhar Pedamallu, Gordon Saksena, Steven E. Schumacher
Nature. 20146,576 CitationsOPEN ACCESS
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesús M. Bañales, José J.G. Marı́n, Ángela Lamarca, Pedro M. Rodrigues, Shahid A. Khan, Lewis R. Roberts, Vincenzo Cardinale, Guido Carpino, Jesper B. Andersen, Chiara Braconi, Diego F. Calvisi, María J. Perugorria, Luca Fabris, Luke Boulter, Rocı́o I.R. Macı́as, Eugenio Gaudio, Domenico Alvaro, Sergio A. Gradilone, Mario Strazzabosco, Marco Marzioni, Cédric Coulouarn, Laura Fouassier, Chiara Raggi, Pietro Invernizzi, Joachim C. Mertens, Anja Moncsek, Sumera I. Ilyas, Julie K. Heimbach, Bas Groot Koerkamp, Jordi Bruix, Alejandro Forner, John Bridgewater, Juan W. Valle, Gregory J. Gores
S120397320. 20202,520 CitationsOPEN ACCESS
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
Robin Kate Kelley, Makoto Ueno, Changhoon Yoo, Richard S. Finn, Junji Furuse, Zhenggang Ren, Thomas Yau, Heinz‐Josef Klümpen, Stephen L. Chan, Masato Ozaka, Chris Verslype, Mohamed Bouattour, Joon Oh Park, Olga Barajas, Uwe Pelzer, Juan W. Valle, Li Yu, Usha Malhotra, Abby B. Siegel, Julien Edeline, Arndt Vogel, Arndt Vogel, Mehmet Akce, Inmaculada Alés Díaz, Gustavo R. Alves, Sumitra Anand, Çağatay Arslan, Jamil Asselah, Eric Assenat, F. Aubin, Li‐Yuan Bai, Yuxian Bai, Olga Barajas, Susan E. Bates, Stephen Begbie, Irit Ben‐Aharon, Nina Beri, Marie‐Luise Berres, Jean‐Frédéric Blanc, Ivan Borbath, Robert Bordonaro, Mohamed Bouattour, Giovanni Brandi, Adam M. Burgoyne, Kritiya Butthongkomvong, Marcos Pedro Guedes Camandaroba, Ke Cao, Marcela Carballido, Jen‐Shi Chen, Jen‐Shi Chen, Ming-Huang Chen, Ashley Cheng, Ashley Cheng, Tai‐Jan Chiu, Hye Jin Choi, Hong Jae Chon, Joëlle Collignon, Antonio Cubillo Gracián, S. Lindsey Davis, Ricardo Saraiva de Carvalho, D.J.A. de Groot, Anne Demols, Judith de Vos, Maria Diab, Jacob C. Easaw, Martin Eatock, Julien Edeline, Rawad Elias, Fredericus Eskens, Alfredo Falcone, Plinio Fernández, Richard Finn, Fábio Franke, Masayuki Furukawa, Junji Furuse, Olumide B. Gbolahan, Karen Geboes, Keri-Lee Geneser, Zhimin Geng, Ravit Geva, Roopinder Gillmore, Thorsten Oliver Goetze, Hongfeng Gou, Julieta Grasselli, Shanzhi Gu, Mahmut Gümüş, Nadia Haj Mohammad, Chunyi Hao, Hakan Harputluoğlu, Hassan Hatoum, Volker Heinemann, Wang Kwong Ho, Chiun Hsu, Ayala Hubert, Jun‐Eul Hwang, Mevlüde İnanç, Soledad Iseas, Vaishnavi Jeyasingam, Paula Jiménez Fonseca, Warren Joubert
The Lancet. 20231,086 CitationsOPEN ACCESS
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
Ángela Lamarca, Daniel H. Palmer, Harpreet Wasan, Paul J. Ross, Yuk Ting, Arvind Arora, Stephen Falk, Roopinder Gillmore, Jonathan Wadsley, Kinnari Patel, Alan Anthoney, Anthony Maraveyas, Timothy Iveson, Justin S. Waters, Claire Hobbs, Safia Barber, W. David J. Ryder, John Ramage, Linda Davies, John Bridgewater, Juan W. Valle
The Lancet Oncology. 2021771 CitationsOPEN ACCESS
Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment
Mechteld C. de Jong, Hari Nathan, Georgios C. Sotiropoulos, Andreas Paul, Sorin Alexandrescu, Hugo P. Marques, Carlo Pulitanò, Eduardo Barroso, Bryan M. Clary, Luca Aldrighetti, Cristina R. Ferrone, Andrew X. Zhu, Todd W. Bauer, Dustin M. Walters, T. Clark Gamblin, Kevin T. Nguyen, Ryan S. Turley, Irinel Popescu, Catherine Hubert, Stephanie Meyer, Richard D. Schulick, Michael A. Choti, J. F. Gigot, Gilles Mentha, Timothy M. Pawlik
Journal of Clinical Oncology. 2011754 CitationsOPEN ACCESS

Where is Cholangiocarcinoma and Gallbladder Cancer Studies research published, and who funds it?

ScholarIQvenues & funding sources

TOP JOURNALS

TOP FUNDERS

National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock

How much of the research on Cholangiocarcinoma and Gallbladder Cancer Studies is open access?

ScholarIQopen access share
73%OPEN ACCESS
Gold
0%
Green
27%
Hybrid
27%
Bronze
20%
Closed
27%

Related on ScholarIQ

Comprehensive molecular characterization of gastric adenocarcinoma
Paper
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
Paper
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Paper
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Paper
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Paper
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Paper
470M+ articles · free account